Should I buy or sell Coloplast A/S stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares. View CLPBY analyst ratings or view top-rated stocks .

How have CLPBY shares performed in 2024?

Coloplast A/S's stock was trading at $11.53 at the beginning of the year. Since then, CLPBY stock has increased by 11.6% and is now trading at $12.87. View the best growth stocks for 2024 here .

Are investors shorting Coloplast A/S?

Coloplast A/S saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 7,900 shares, an increase of 203.8% from the March 15th total of 2,600 shares. Based on an average daily volume of 129,900 shares, the days-to-cover ratio is currently 0.1 days. View Coloplast A/S's Short Interest .

How were Coloplast A/S's earnings last quarter?

Coloplast A/S (OTCMKTS:CLPBY) announced its earnings results on Friday, February, 9th. The company reported $0.08 earnings per share for the quarter, hitting analysts' consensus estimates of $0.08. The business had revenue of $953.60 million for the quarter. Coloplast A/S had a trailing twelve-month return on equity of 43.30% and a net margin of 19.48%.

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?

Coloplast A/S declared a dividend on Friday, November 17th. Shareholders of record on Monday, December 11th will be paid a dividend of $0.1498 per share on Friday, December 22nd. The ex-dividend date is Friday, December 8th. This is a boost from the stock's previous dividend of $0.05. Read our dividend analysis for CLPBY .

How do I buy shares of Coloplast A/S?

Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CLPBY

Coloplast A/S (CLPBY) Stock Price, News & Analysis

→ This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad)

Free CLPBY Stock Alerts

$12.87

-0.09 (-0.69%)

(As of 04/18/2024 ET)

Compare

Today's Range: $12.84
▼
$12.98
50-Day Range: $12.34
▼
$14.30
52-Week Range: $9.90
▼
$14.77

Volume: 51,657 shs
Average Volume: 104,139 shs
Market Capitalization: N/A

P/E Ratio: 39.00
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Analyst Forecasts Chart Dividend Earnings Financials Headlines SEC Filings Short Interest

Get Coloplast A/S alerts:

Ad Paradigm Press

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

About Coloplast A/S Stock (OTCMKTS:CLPBY)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

CLPBY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CLPBY Stock News Headlines

April 18, 2024 | americanbankingnews.com

Contrasting Coloplast A/S (OTCMKTS:CLPBY) & Envoy Medical (NASDAQ:COCH)

March 1, 2024 | globenewswire.com

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

April 18, 2024 | Paradigm Press (Ad)

AI “wealth window” is closing soon!

Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.

February 28, 2024 | globenewswire.com

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons

February 23, 2024 | finance.yahoo.com

Coloplast A/S (CLPBY)

February 12, 2024 | finance.yahoo.com

Coloplast A/S: Coloplast Earnings: Underlying Demand Remains Strong, but Medicare Fraudsters Could Hurt U.S. Growth

February 9, 2024 | finance.yahoo.com

Coloplast A/S - Allocation of Share Options

February 9, 2024 | globenewswire.com

Coloplast A/S - Allocation of Share Options

April 18, 2024 | WealthPress (Ad)

Chances are you know the firms on this list

These are the entities that can buy MILLIONS of shares in a single day… I’m talking about huge orders that literally move the share price 1%, 2%, even 5% or more in the process. Why am I showing you that list? Well, because if you have a way to successfully detect which stocks these elite traders are likely buying in real time… All you have to do is ride the coattails of their massive orders and you can target endless trading opportunities without leaving your money exposed to the markets for too long. And in case you didn’t already know…

February 9, 2024 | finance.yahoo.com

Coloplast A/S - Interim Financial Report, Q1 2023/24

February 9, 2024 | finance.yahoo.com

Coloplast launches Peristeen® Light for people with bowel disorders

February 7, 2024 | morningstar.com

Coloplast A/S ADR

January 31, 2024 | finance.yahoo.com

Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US

December 7, 2023 | msn.com

Coloplast A/S goes ex-dividend tomorrow

November 14, 2023 | finance.yahoo.com

Coloplast A/S - Notice of Annual General Meeting 2023

November 9, 2023 | finance.yahoo.com

Coloplast A/S: Coloplast Earnings: Revenue Growth Remains Solid, but Margin Drag Likely to Last Into 2024

September 1, 2023 | finance.yahoo.com

Coloplast A/S - Announcement no. 08/2023 - Coloplast announces registration of share capital increase of 12.2 new B shares completed

August 18, 2023 | finance.yahoo.com

Major shareholder notification

August 17, 2023 | finance.yahoo.com

Coloplast A/S - Announcement no. 04/2023 - Interim Financial Report, 9M 2022/2023

July 7, 2023 | finance.yahoo.com

Coloplast A/S - Announcement no. 03/2023 - Coloplast announces agreement to acquire Kerecis and raises long-term growth expectations

May 19, 2023 | seekingalpha.com

CLPBY Coloplast A/S

May 13, 2023 | msn.com

Coloplast AS - Class B (CLPBF) Declares $5.00 Dividend

May 11, 2023 | finance.yahoo.com

Coloplast A/S - Announcement no. 02/2023 - Interim Financial Report, H1 2022/23

May 7, 2023 | cbsnews.com

Sam's Club May 2023 membership deal: Get one year of discounted gas, food and more for $35

April 24, 2023 | finance.yahoo.com

New clinical study demonstrates significant improvement in pulmonary health and related symptoms when using Provox® Life™

April 5, 2023 | benzinga.com

Short Volatility Alert: Coloplast

March 28, 2023 | cbsnews.com

Sam's Club March membership deal: Get one year of discounted gas, groceries and more for $25

See More Headlines

Receive CLPBY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Coloplast A/S and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/09/2024
Today: 4/18/2024
Fiscal Year End: 9/30/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Current Symbol: OTCMKTS:CLPBY
Previous Symbol: NASDAQ:CLPBY
CUSIP: N/A
CIK: 1294325
Web: www.coloplast.com
Phone: (454) 911-1111
Fax: N/A
Employees: 15,913
Year Founded: 1954

Profitability

EPS (Most Recent Fiscal Year): $0.33
Trailing P/E Ratio: 39.27
Forward P/E Ratio: 37.03
P/E Growth: 3.07
Net Income: $685.88 million
Net Margins: 19.48%
Pretax Margin: 24.59%
Return on Equity: 43.30%
Return on Assets: 11.89%

Debt

Debt-to-Equity Ratio: 0.76
Current Ratio: 0.53
Quick Ratio: 0.35

Sales & Book Value

Annual Sales: $3.58 billion
Price / Sales: N/A
Cash Flow: $0.43 per share
Price / Cash Flow: 30.43
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: -0.04

Social Links

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Mr. Kristian Villumsen (Age 54)
President & CEO
Comp: $2.55M
Mr. Anders Lonning-Skovgaard (Age 52)
Executive VP & CFO
Comp: $1.31M
Mr. Allan Rasmussen (Age 57)
Executive Vice President of Global Operations
Comp: $1.15M
Mr. Nicolai Buhl Andersen (Age 55)
Executive Vice President of Innovation
Comp: $1.11M
Mr. Paul Marcun (Age 57)
Executive Vice President of Growth
Comp: $1.33M
Mr. Thomas Barfod (Age 54)
Senior Controller & Employees Representative Director
Comp: $65.68k
Ellen Bjurgert
Vice President of Investor Relations
Dennis Kaysen
Director of Corporate Communications
Dorthe Ronnau (Age 58)
Senior Vice President of People & Culture
Mr. Alain Morvan
Senior Vice President of Sales Europe

Key Competitors

View All Competitors

Should I Buy Coloplast A/S Stock? CLPBY Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Coloplast A/S:

Coloplast A/S engages in the development and sale of intimate healthcare products and services globally, providing a diversified revenue stream.
The company offers innovative products like SenSura Mio and SpeediCath catheters, catering to a growing market for healthcare solutions.
Coloplast A/S operates in various segments including Chronic Care, Continence Care, and Advanced Wound Care, showcasing a broad product portfolio.
Recent financial reports indicate strong performance, with revenue growth and profitability, making it an attractive investment option.
The current stock price of Coloplast A/S reflects positive market sentiment and potential for future growth.

Cons

Investors should be bearish about investing in Coloplast A/S for these reasons:

Market competition in the healthcare sector could impact Coloplast A/S's market share and pricing power.
Regulatory changes or challenges in different regions may affect the company's operations and profitability.
Fluctuations in currency exchange rates could pose risks to Coloplast A/S's international business operations.
Economic uncertainties or global events could impact consumer demand for healthcare products, affecting the company's sales.
Investors should carefully monitor industry trends and company performance to make informed investment decisions.

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 11, 2024. Please send any questions or comments about these Coloplast A/S pros and cons to contact@marketbeat.com.

CLPBY Stock Analysis - Frequently Asked Questions

Should I buy or sell Coloplast A/S stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Coloplast A/S in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CLPBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLPBY, but not buy additional shares or sell existing shares.
View CLPBY analyst ratings or view top-rated stocks.
How have CLPBY shares performed in 2024?: Coloplast A/S's stock was trading at $11.53 at the beginning of the year. Since then, CLPBY stock has increased by 11.6% and is now trading at $12.87.
View the best growth stocks for 2024 here.
Are investors shorting Coloplast A/S?: Coloplast A/S saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 7,900 shares, an increase of 203.8% from the March 15th total of 2,600 shares. Based on an average daily volume of 129,900 shares, the days-to-cover ratio is currently 0.1 days.
View Coloplast A/S's Short Interest.
How were Coloplast A/S's earnings last quarter?: Coloplast A/S (OTCMKTS:CLPBY) announced its earnings results on Friday, February, 9th. The company reported $0.08 earnings per share for the quarter, hitting analysts' consensus estimates of $0.08. The business had revenue of $953.60 million for the quarter. Coloplast A/S had a trailing twelve-month return on equity of 43.30% and a net margin of 19.48%.

How often does Coloplast A/S pay dividends? What is the dividend yield for Coloplast A/S?: Coloplast A/S declared a dividend on Friday, November 17th. Shareholders of record on Monday, December 11th will be paid a dividend of $0.1498 per share on Friday, December 22nd. The ex-dividend date is Friday, December 8th. This is a boost from the stock's previous dividend of $0.05.
Read our dividend analysis for CLPBY.
How do I buy shares of Coloplast A/S?: Shares of CLPBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CLPBY) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Coloplast A/S (CLPBY) Stock Price, News & Analysis

About Coloplast A/S Stock (OTCMKTS:CLPBY)

CLPBY Stock Price History

CLPBY Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Should I Buy Coloplast A/S Stock? CLPBY Pros and Cons Explained

Pros

Cons

CLPBY Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info